NCT06933875 Promoting Palliative Care for People With Heart Failure
| NCT ID | NCT06933875 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,260 participants |
| Start Date | 2026-07-02 |
| Primary Completion | 2027-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,260 participants in total. It began in 2026-07-02 with a primary completion date of 2027-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.
Eligibility Criteria
Inclusion Criteria: Healthcare providers must meet the following criteria: * Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate * Has ordering privileges * Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service) * Anticipate employment at one of the two study sites for the 15-month trial period. Or * Palliative care team member * Hospital administrator/quality and safety personnel Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization: * Age 18 years of age or older * N-terminal pro-B-type natriuretic peptide values of \>500 pg/ml * Received intravenous diuretics within 24 hours of admission. Exclusion Criteria: * Pregnant at the time of admission.
Contact & Investigator
Shelli Feder, PhD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT06933875 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06933875 currently recruiting?
Yes, NCT06933875 is actively recruiting participants. Contact the research team at shelli.feder@yale.edu for enrollment information.
Where is the NCT06933875 trial being conducted?
This trial is being conducted at New Haven, United States, New Haven, United States.
Who is sponsoring the NCT06933875 clinical trial?
NCT06933875 is sponsored by Yale University. The principal investigator is Shelli Feder, PhD at Yale University. The trial plans to enroll 2,260 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.